Morpholino

MO1-crabp2a

ID

ZDB-MRPHLNO-120608-2

Name

MO1-crabp2a

Previous Names

None

Target

crabp2a (1)

Sequence

5' - CGGGAATTTTACGATCCATCTTCCG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-crabp2a

Expressed Gene	Anatomy	Figures
egr2b	rhombomere 3 rhombomere 5	Fig. 1 , Fig. 2 from Cai et al., 2012
hoxb4a	rhombomere 7 rhombomere 8	Fig. 1 , Fig. 2 from Cai et al., 2012
hoxb5a	spinal cord neural tube	Fig. 1 from Cai et al., 2012
pax2a	midbrain hindbrain boundary	Fig. 1 , Fig. 2 from Cai et al., 2012

Phenotype

Phenotype resulting from MO1-crabp2a

No data available

Phenotype of all Fish created by or utilizing MO1-crabp2a

Phenotype	Fish	Conditions	Figures
rhombomere 3 poorly differentiated, abnormal	WT + MO1-crabp2a	chemical treatment: all-trans-retinoic acid	Fig. 2 from Cai et al., 2012
midbrain hindbrain boundary poorly differentiated, abnormal	WT + MO1-crabp2a	chemical treatment: all-trans-retinoic acid	Fig. 2 from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal	WT + MO1-crabp2a	chemical treatment: all-trans-retinoic acid	Fig. 2 from Cai et al., 2012
hindbrain wholly posteriorized, abnormal	WT + MO1-crabp2a + MO1-crabp2b	chemical treatment: all-trans-retinoic acid	Fig. 1 from Cai et al., 2012
retinoic acid receptor signaling pathway decreased process quality, abnormal	WT + MO1-crabp2a + MO1-crabp2b	standard conditions	Fig. 1 from Cai et al., 2012
rhombomere 7 poorly differentiated, abnormal	WT + MO1-crabp2a + MO1-crabp2b	standard conditions	Fig. 1 from Cai et al., 2012
rhombomere 7 poorly differentiated, abnormal	WT + MO1-crabp2a + MO1-crabp2b	chemical treatment: all-trans-retinoic acid	Fig. 1 from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal	WT + MO1-crabp2a + MO1-crabp2b	standard conditions	Fig. 1 from Cai et al., 2012
spinal cord neural tube poorly differentiated, abnormal	WT + MO1-crabp2a + MO1-crabp2b	chemical treatment: all-trans-retinoic acid	Fig. 1 from Cai et al., 2012
spinal cord neural tube poorly differentiated, abnormal	WT + MO1-crabp2a + MO1-crabp2b	standard conditions	Fig. 1 from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal	WT + MO1-crabp2a + MO1-crabp2b	chemical treatment: all-trans-retinoic acid	Fig. 1 from Cai et al., 2012
retinoic acid receptor signaling pathway increased process quality, abnormal	ld1Tg + MO1-crabp2a + MO1-crabp2b	chemical treatment: all-trans-retinoic acid	Fig. S6 from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal	ld1Tg + MO1-crabp2a + MO1-crabp2b	chemical treatment: all-trans-retinoic acid	Fig. S6 from Cai et al., 2012

Citations